Q Bio Stock
On a mission to build the first Clinical Digital Twin Platform and make it accessible to everyone
Sign up today and learn more about Q Bio Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Q Bio Stock
Q Bio was founded in 2015 by Jeffrey Kaditz, serial entrepreneur and Founder of Affirm, Dr Michael Snyder, Chair of Genetics and Director of Personalized Medicine and Stanford University, and Dr Garry Choy, physician, radiologist, and former Chief Medical Information Officer at Mass General Hospital. Q Bio is fortunate to be backed by some of the best venture groups in the world including: A16Z, Khosla Ventures, Founders Fund, SciFi VC, and Kevin Durant. This interdisciplinary team based in San Carlos, CA is comprised of pioneers in fields such applied math, computational physics, electrical engineering, genetics, and radiology, hail from a dizzying array of home countries and cultural backgrounds.
Funding History
| January 2016 | $7.5M |
|---|---|
| January 2018 | $16.5M |
| February 2020 | $60.0M |
Management
Founder, CEO & CTO
Jeffrey Kaditz
COO
Clarissa Shen
Founder & Chief Medical Officer
Garry Choy
Founder
Michael Snyder
Board Member
Vinod Khosla
VP of Platform Engineering
Jyotindra Vasudeo
Investor
Patrick Schneider-Sikorsky
VP of Radiomics
Thomas Witzel
Board Member
Vijay Pande
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
